Abstract
The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Current Molecular Medicine
Title:Do Genetic Factors Predispose People to COVID-19: A Review Article
Volume: 21 Issue: 6
Author(s): Ava Nasrolahi, Karimeh Haghani, Ali Gheysarzadeh and Salar Bakhtiyari*
Affiliation:
- Department of Clinical Biochemistry, School of Medicine, Ilam University of Medical Sciences, Ilam,Iran
Keywords: COVID-19, SARS-CoV-2, Age, Race, Gender, Smoking status, Genetic susceptibility, Immune system, Underlying diseases.
Abstract: The pandemic of coronavirus disease 2019 (COVID-19) has become a threat to human life and society. Scientists and clinicians are struggling with the intrusive SARS-CoV-2 virus to enhance their knowledge about its pathogenesis and find an effective medicine and vaccine to combat its complications. Till now, they have learned that this SARS-CoV-2 has not infected all people exposed to this virus, and also severe respiratory illnesses have not been observed in all infected patients. Patients over 65 or with underlying diseases are more vulnerable to develop severe disease. Based on this premise, a highly challenging question is why some people are more susceptible to this virus and others are not. The present study was aimed to review the current information, which explains the broad spectrum of COVID-19 presentation. Here, we discussed how genetic background, immune system, underlying disease, smoking status, as well as age, race, and gender affect COVID-19 susceptibility.
Export Options
About this article
Cite this article as:
Nasrolahi Ava , Haghani Karimeh , Gheysarzadeh Ali and Bakhtiyari Salar *, Do Genetic Factors Predispose People to COVID-19: A Review Article, Current Molecular Medicine 2021; 21 (6) . https://dx.doi.org/10.2174/1566524020999201113102145
DOI https://dx.doi.org/10.2174/1566524020999201113102145 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
In Silico Identification of a Potent Arsenic Based Approved Drug Darinaparsin against SARS-CoV-2: Inhibitor of RNA Dependent RNA polymerase (RdRp) and Essential Proteases
Infectious Disorders - Drug Targets Therapeutic Targets and Computational Approaches on Drug Development for COVID-19
Current Topics in Medicinal Chemistry Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight
Current Pharmaceutical Biotechnology Pulmonary Rehabilitation in COVID-19: The Contribution of other Chronic Lung Syndromes for the Intervention of a Novel Disease
Current Respiratory Medicine Reviews The Challenges of Biomedical Waste Management During the Ongoing Coronavirus Disease-19 (COVID-19) Pandemic: The Current Scenario
Micro and Nanosystems Efficacy of Lopinavir/Ritonavir Compared With Standard Care for Treatment of Coronavirus Disease 2019 (COVID-19): A Systematic Review
Infectious Disorders - Drug Targets Nanotechnology can Provide Therapeutic Agent by Targeting Molecular Structures of SARS-CoV-2 (COVID-19): A Mini-Review
Letters in Drug Design & Discovery COVID-19 Epigenetics and Implications for Public Health
Coronaviruses COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development
Pharmaceutical Nanotechnology Synthetic Peptides for the Immunodiagnosis of Human Diseases
Current Medicinal Chemistry Exposure to Perinatal Infections and Bipolar Disorder: A Systematic Review
Current Molecular Medicine Knowledge Evaluation of Hand Hygiene and Infectious Diseases in Lebanon
Coronaviruses The Effects of Coronavirus (COVID-19) on the Psychological Health of Indian Poultry Farmers
Coronaviruses Role of Pulmonary Ultrasound in COVID-19 Pandemics
Current Respiratory Medicine Reviews Impact of COVID-19 on Mental Dimension of Health: A Sensitive Issue to be Addressed at the Earliest
Current Psychiatry Research and Reviews Chronic Diarrhea and AIDS: Insights into Studies with Non-Human Primates
Current HIV Research Therapeutic Measures for the Novel Coronavirus: A Review of Current Status and Future Perspective
Current Molecular Medicine Facts and Myths: Efficacies of Repurposing Chloroquine and Hydroxychloroquine for the Treatment of COVID-19
Current Drug Targets The Interplay Among Epilepsy, Parkinson’s Disease and Inflammation: Revisiting the Link through Ca<sup>2+</sup>/cAMP Signalling
Current Neurovascular Research COVID-19 Severity: Lung-Heart Interplay
Current Cardiology Reviews